AbobotulinumtoxinA: A New Therapy for Hip Osteoarthritis. A Prospective Randomized Double-Blind Multicenter Study

Hip Osteoarthritis (OA) causes pain and disability. Here we evaluate abobotulinumtoxinA (Dysport(®)) (AboBoNT-A) injections versus placebo as a novel treatment option to improve hip range of motion, pain and quality of life. This prospective randomized double-blind multicenter study (EudraCT # 2012-...

Descripción completa

Detalles Bibliográficos
Autores principales: Eleopra, Roberto, Rinaldo, Sara, Lettieri, Christian, Santamato, Andrea, Bortolotti, Paolo, Lentino, Carmelo, Tamborino, Carmine, Causero, Araldo, Devigili, Grazia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266300/
https://www.ncbi.nlm.nih.gov/pubmed/30384438
http://dx.doi.org/10.3390/toxins10110448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266300/
https://www.ncbi.nlm.nih.gov/pubmed/30384438
http://dx.doi.org/10.3390/toxins10110448

Ejemplares similares